GlobeStar Therapeutics

GSTC · OTC

$0.00+$0.00 (+0.00%)TodayMarket closed · Oct 13, 1:11 PM ET

No price history for this range.

About GSTC

GlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company is headquartered in Richland, Washington. The company went IPO on 2011-05-21. The firm is focused on introducing a patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The firm owns the global license from the inventors, who are based in Italy.

Employees: 0
Headquarters: Richland, Washington
Listed: May 21, 2011
Sector: Health Care
Industry: Biotechnology
Website: globestarthera.com

Leadership

GlobeStar Therapeutics executives
Name	Title	Since	Age
James Katzaroff	—	2020	66
Robert Chicoski	—	—	81
William Farley	—	—	68
Steven Penderghast	—	—	—

Similar companies

Companies in the same industry as GlobeStar Therapeutics

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.